Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Medis Pharma Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (1052)
ARTG (149)
Cancellation or suspension (26)
Listed medicine compliance report (5)
Prescription medicine registration (2)

Date

2024 (866)
2023 (3)
2022 (29)
2021 (106)
2020 (31)
2019 (6)
2018 (6)
2017 (47)
2016 (5)
2015 (29)
2014 (29)
2013 (29)
2012 (23)
2011 (12)
2010 (3)
2009 (8)
2008 (1)
1993 (1)

Results for "[search-keyword]"

Search

Sponsor content

1234 result(s) found, displaying 901 to 910

METFORMIN-AS metformin hydrochloride 1000 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

10 September 2021

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
METFORMIN-AS metformin hydrochloride 850mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

10 September 2021

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
METFORMIN-AS metformin hydrochloride 500mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

10 September 2021

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
DIAMET metformin hydrochloride 850mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

10 September 2021

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
DIAMET metformin hydrochloride 500mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

10 September 2021

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
ROXITHROMYCIN-AS roxithromycin 300mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

4 September 2021

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
ROXITHROMYCIN-AS roxithromycin 150mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

4 September 2021

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
PANTOPRAZOLE-MEDIS pantoprazole(as sodium sesquihydrate) 40 mg enteric-coated tablet blister Cancelled under Section 30(1)(c) of the Act

22 June 2021

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
PACLITAXEL ACT paclitaxel 100 mg/16.67 mL concentrated injection vial Cancelled under Section 30(1)(c) of the Act

22 June 2021

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
DUTRAN 12 fentanyl 12 mcg/hr transdermal patch pouch Cancelled under Section 30(1)(c) of the Act

16 June 2021

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd

Pages

First page
Previous page
…
Page 87
Page 88
Page 89
Page 90
Current page 91
Page 92
Page 93
Page 94
Page 95
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.